Oxeon Partners
Oxeon is a New York-based healthcare executive search and investment firm founded in 2011. The company specializes in connecting visionary leaders with innovative ideas to advance the healthcare sector. Oxeon operates as a healthcare growth services firm, focusing on uniting partners with key drivers of business growth, including top talent and strategic investments. The firm comprises three main entities: Oxeon Search, which has successfully placed over 1,000 executives in healthcare leadership roles; Oxeon Investments, which makes selective seed investments to foster change in healthcare; a
Investing activity
Oxeon Partners appears in 1 AI deal tracked by the Lounge deals desk, rounds totalling $18M. The rounds are mostly Seed, with a median round size of $18M. The most recent is UpDoc (Seed, $18M, Jun 2026).
Oxeon Partners most often invests alongside American Diabetes Association, Lilly Ventures, Polaris Partners and S32, and the companies it backs on Lounge are mostly in AI.
Deals
Frequently asked questions about Oxeon Partners
What AI companies has Oxeon Partners invested in?
Oxeon Partners's AI investments include UpDoc. The 1 round on Lounge are listed on this page with amounts, dates and co-investors.
Where is Oxeon Partners based?
Oxeon Partners is based in New York, New York, United States.
What stage does Oxeon Partners invest at?
In the rounds tracked on Lounge, Oxeon Partners has invested at Seed, with a median round of $18M.
Who does Oxeon Partners co-invest with?
Oxeon Partners's most frequent co-investors on Lounge are American Diabetes Association (1 deal), Lilly Ventures (1 deal), Polaris Partners (1 deal), S32 (1 deal) and Pear (1 deal).
How can founders reach Oxeon Partners?
Founders on Lounge can see Oxeon Partners's contact details in AI Investor Contacts (paid plans), check for a warm introduction through members who worked with the firm under Warm Paths, and add Oxeon Partners to their Investor Pipeline to track the conversation.